Satoris to Distribute RBM's Biomarker Panel for Neuro Research | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Satoris today said that it has been appointed global distributor for Rules-Based Medicine's DiscoveryMAP panel for neurology research.

The RBM DisocveryMAP is a 189-biomarker panel that covers the most physiologically relevant pathways and includes biomarkers known to be important in the major disease processes for drug development, said Redwood City, Calif.-based Satoris in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.